Sarmad A. Araji-Al

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.

Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 17, 2026

Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profile.

Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profile.

Journal: BMJ open
Published: September 25, 2025

Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis.

Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis.

Journal: Neurology
Published: August 07, 2025

Real-world evaluation of subcutaneous natalizumab in patients with highly active relapsing-remitting multiple sclerosis.

Real-world evaluation of subcutaneous natalizumab in patients with highly active relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: August 06, 2025

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis.

Journal: BMJ neurology open
Published: June 11, 2025

Real-World Comparison of High-Efficacy Versus Non-High-Efficacy Therapies in Multiple Sclerosis.

Real-World Comparison of High-Efficacy Versus Non-High-Efficacy Therapies in Multiple Sclerosis.

Journal: Annals of clinical and translational neurology
Published: March 11, 2025

Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap.

Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap.

Journal: Neurology
Published: November 04, 2024

The temporal dynamics and clinical relevance of choroid plexus measures in multiple sclerosis.

The temporal dynamics and clinical relevance of choroid plexus measures in multiple sclerosis.

Journal: Brain communications
Published: October 05, 2024

Investigating the association between grey matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling.

Investigating the association between grey matter hypoperfusion and atrophy in multiple sclerosis using arterial spin labelling.

Journal: Brain communications
Published: June 20, 2024

Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.

Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 26, 2023

Treatment-refractory warts associated with fingolimod.

Treatment-refractory warts associated with fingolimod.

Journal: Practical neurology
Published: July 18, 2022

A possible case of serum sickness after ocrelizumab infusion - Commentary.

A possible case of serum sickness after ocrelizumab infusion - Commentary.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 20, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026